$176 Million is the total value of Forefront Analytics, LLC's 67 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 16.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VWO | Buy | VANGUARD INTL EQUITY INDEX Fftse emr mkt etf | $15,970,577 | +6.7% | 407,309 | +10.7% | 9.06% | +6.1% |
| VEA | Buy | VANGUARD TAX-MANAGED FDSvan ftse dev mkt | $13,404,018 | +7.7% | 306,588 | +13.7% | 7.60% | +7.0% |
| SPY | Buy | SPDR S&P 500 ETF TRtr unit | $9,249,656 | +5.6% | 21,638 | +9.5% | 5.24% | +5.0% |
| ESGG | New | FLEXSHARES TRstox gbl esg slt | $7,811,784 | – | 57,889 | +100.0% | 4.43% | – |
| HDV | Buy | ISHARES TRcore high dv etf | $6,072,746 | +5.7% | 61,409 | +7.8% | 3.44% | +5.1% |
| VNQ | Buy | VANGUARD INDEX FDSreal estate etf | $4,922,401 | +6.3% | 65,058 | +17.4% | 2.79% | +5.7% |
| EDV | Buy | VANGUARD WORLD FDextended dur | $4,761,234 | -4.4% | 67,987 | +18.8% | 2.70% | -5.0% |
| VNQI | Buy | VANGUARD INTL EQUITY INDEX Fglb ex us etf | $3,454,878 | +9.1% | 88,745 | +12.6% | 1.96% | +8.4% |
| LQD | Buy | ISHARES TRiboxx inv cp etf | $3,146,720 | +8.0% | 30,846 | +14.5% | 1.78% | +7.3% |
| EMB | Buy | ISHARES TRjpmorgan usd emg | $2,578,198 | +3.6% | 31,244 | +8.6% | 1.46% | +3.0% |
| BKLN | Buy | INVESCO EXCH TRADED FD TR IIsr ln etf | $2,484,669 | +11.2% | 118,372 | +11.5% | 1.41% | +10.6% |
| VB | Buy | VANGUARD INDEX FDSsmall cp etf | $2,413,941 | +6.8% | 12,768 | +12.4% | 1.37% | +6.2% |
| STIP | Buy | ISHARES TR0-5 yr tips etf | $2,079,017 | -0.5% | 21,451 | +0.2% | 1.18% | -1.1% |
| MBB | Buy | ISHARES TRmbs etf | $2,008,922 | +14.3% | 22,623 | +20.1% | 1.14% | +13.7% |
| FLRN | Buy | SPDR SER TRbloomberg invt | $1,883,352 | +1.0% | 61,307 | +0.9% | 1.07% | +0.4% |
| DJP | Buy | BARCLAYS BANK PLCdjubs cmdt etn36 | $1,703,549 | +31.3% | 53,004 | +24.9% | 0.97% | +30.5% |
| BNDX | Buy | VANGUARD CHARLOTTE FDStotal int bd etf | $1,578,653 | +4.7% | 33,006 | +7.0% | 0.90% | +4.1% |
| VTV | Buy | VANGUARD INDEX FDSvalue etf | $1,574,168 | +1.3% | 11,412 | +4.3% | 0.89% | +0.7% |
| PDP | Buy | INVESCO EXCHANGE TRADED FD Tdorsey wright mo | $1,492,205 | -5.0% | 19,382 | +0.0% | 0.85% | -5.6% |
| SHV | Buy | ISHARES TRshort treas bd | $1,342,612 | +0.6% | 12,154 | +0.6% | 0.76% | 0.0% |
| FLOT | Buy | ISHARES TRfltg rate nt etf | $1,055,978 | +1.6% | 20,750 | +1.5% | 0.60% | +1.0% |
| XLRE | Buy | SELECT SECTOR SPDR TRrl est sel sec | $946,013 | -8.8% | 27,766 | +0.8% | 0.54% | -9.5% |
| USMV | Buy | ISHARES TRmsci usa min vol | $837,148 | +8.6% | 11,567 | +11.5% | 0.48% | +8.0% |
| BSCU | Buy | INVESCO EXCH TRD SLF IDX FDinvsco 30 corp | $679,590 | -2.9% | 43,619 | +0.9% | 0.38% | -3.5% |
| INDA | New | ISHARES TRmsci india etf | $614,348 | – | 13,893 | +100.0% | 0.35% | – |
| TLT | Buy | ISHARES TR20 yr tr bd etf | $534,623 | -13.2% | 6,028 | +0.8% | 0.30% | -13.7% |
| JPM | Buy | JPMORGAN CHASE & CO | $503,534 | +0.3% | 3,472 | +0.6% | 0.29% | 0.0% |
| UWM | Buy | PROSHARES TR | $438,356 | -12.1% | 14,501 | +0.1% | 0.25% | -12.3% |
| SCHA | Buy | SCHWAB STRATEGIC TRus sml cap etf | $428,544 | -5.1% | 10,346 | +0.4% | 0.24% | -5.8% |
| VWOB | Buy | VANGUARD WHITEHALL FDSem mk gov bd etf | $361,973 | -4.1% | 6,119 | +0.9% | 0.20% | -4.7% |
| JNK | Buy | SPDR SER TRbloomberg high y | $285,248 | -1.7% | 3,155 | +0.1% | 0.16% | -2.4% |
| INCY | Buy | INCYTE CORP | $204,390 | -7.1% | 3,538 | +0.1% | 0.12% | -7.2% |
| New | ORCHARD THERAPEUTICS PLCspon ads new | $109,634 | – | 14,183 | +100.0% | 0.06% | – | |
| New | ZURA BIO LTD | $95,462 | – | 14,464 | +100.0% | 0.05% | – | |
| FUSN | Buy | FUSION PHARMACEUTICALS INC | $87,581 | -6.6% | 33,685 | +67.8% | 0.05% | -5.7% |
| Buy | JASPER THERAPEUTICS INC | $77,556 | -18.4% | 110,792 | +59.7% | 0.04% | -18.5% | |
| ANNX | Buy | ANNEXON INC | $74,766 | -20.7% | 31,680 | +18.3% | 0.04% | -22.2% |
| ACHL | Buy | ACHILLES THERAPEUTICS PLCsponsored ads | $71,126 | +0.6% | 78,169 | +4.5% | 0.04% | 0.0% |
| ALXO | New | ALX ONCOLOGY HLDGS INC | $66,092 | – | 13,769 | +100.0% | 0.04% | – |
| GERN | Buy | GERON CORP | $61,726 | +29.1% | 29,116 | +95.5% | 0.04% | +29.6% |
| NKTX | Buy | NKARTA INC | $55,124 | +142.8% | 39,657 | +282.5% | 0.03% | +138.5% |
| KRON | Buy | KRONOS BIO INC | $51,959 | -22.7% | 39,968 | +2.3% | 0.03% | -23.7% |
| New | THESEUS PHARMACEUTICALS INC | $47,539 | – | 17,672 | +100.0% | 0.03% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- GKFO LLC #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| PIMCO ETF TR | 24 | Q3 2023 | 7.9% |
| SPDR S&P 500 ETF TR | 24 | Q3 2023 | 10.6% |
| VANGUARD TAX-MANAGED INTL FD | 24 | Q3 2023 | 7.6% |
| DBX ETF TR | 24 | Q3 2023 | 6.0% |
| VANGUARD WORLD FD | 24 | Q3 2023 | 8.0% |
| ISHARES TR | 24 | Q3 2023 | 6.2% |
| ISHARES TR | 24 | Q3 2023 | 5.8% |
| FIRST TR EXCHANGE-TRADED FD | 24 | Q3 2023 | 6.3% |
| ISHARES TR | 24 | Q3 2023 | 5.8% |
| ISHARES INC | 24 | Q3 2023 | 6.0% |
View Forefront Analytics, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-08 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-10 |
| 13F-HR | 2022-05-09 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-15 |
View Forefront Analytics, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.